Clinical trial NCT06342518: ESWT in Lateral Epicondylitis: Clinical,Ultrasonographic Evaluation
Official title: Clinical and Sonographic Evaluation of the Effectiveness of Extracorporeal Shock Wave Therapy (ESWT) in Patients With Lateral Epicondylitis
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Lateral Epicondylitis
Tennis Elbow
Keywords: Extracorporeal Shock Wave Therapy (ESWT)
sonographic assessment
Lateral epicondylitis
Lead sponsor: Istanbul Medeniyet University
Sponsor class: OTHER
First posted: 2024-04-02
Enrollment: 42
Sex: ALL
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study aimed to check and compare how well shock wave therapy works for tennis elbow, both in terms of symptoms and what we can see on ultrasound.

Detailed description: 42 patients with tennis elbow were split into two groups by chance: one group received shock wave therapy (ESWT), while the other received a fake treatment (Sham-ESWT) for comparison. Both groups underwent wrist exercises, splint usage, and ice application. Grip strength, pain levels, and how well they could move their wrist (functionality) were measured before, after, and one month post-treatment using tests. Additionally, the thickness of a common extensor tendon (CET) was evaluated using ultrasound. The patient, the doctor checking the patient, and the doctor doing the ultrasound didn't know which group the patient was in.

Eligibility criteria: Inclusion Criteria:

* experiencing pain and tenderness in the lateral epicondyle while extending their wrist and fingers against resistance for at least 3 months

Exclusion Criteria:

* Patients who are pregnant or have a coagulation disorder, cervical radiculopathy, peripheral neuropathy, peripheral vasculopathy in the upper extremity, complex regional pain syndrome, local infections, systemic inflammatory disease, fibromyalgia syndrome, arthritis (including rheumatoid arthritis, spondylarthritis, and crystal-induced arthropathies), malignancy, or those who have been treated with corticosteroids, PRP, or autologous blood injection, as well as those who have received physical therapy agents, undergone upper-extremity surgical interventions, or have a history of direct trauma to the elbow or a history of fracture,

Primary outcomes:
measure: Hand Grip Strength
timeFrame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)
measure: Pain severity
timeFrame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)
measure: Functionality
timeFrame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)
measure: Quality of life score
timeFrame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)
measure: deep muscular tissue sensitivity
timeFrame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)
measure: thickness of the common extensor tendon (CET)
timeFrame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul Medeniyet University Faculty of Medicine, Physical Medicine and Rehabilitation Department
Study officials:
References: